FDA Advanced Manufacturing Technologies Designation program (from Catapult's regulatory round-up for December 2024)
Year: 2025
Type: other
Abstract: FDA has issued a final guidance for industry entitled “Advanced Manufacturing Technologies Designation Program.” This guidance provides recommendations to persons and organisations interested in participating in the program, which facilitates the development of drugs manufactured using Advanced Manufacturing Technologies (AMT) that has been designated as such under the program. Early adoption of AMTs by the pharmaceutical industry is encouraged by the FDA as it can improve the reliability an...
DOI: 10.58079/13ay3
Author: Adelage
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W6973929279
Cites:
Cited by:
Related to: